These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33879542)

  • 1. The Caveolin-1 Scaffolding Domain Peptide Reverses Aging-Associated Deleterious Changes in Multiple Organs.
    Kuppuswamy D; Chinnakkannu P; Reese C; Hoffman S
    J Pharmacol Exp Ther; 2021 Jul; 378(1):1-9. PubMed ID: 33879542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of angiotensin II-induced pathological changes in heart and kidney by the caveolin-1 scaffolding domain peptide.
    Chinnakkannu P; Reese C; Gaspar JA; Panneerselvam S; Pleasant-Jenkins D; Mukherjee R; Baicu C; Tourkina E; Hoffman S; Kuppuswamy D
    PLoS One; 2018; 13(12):e0207844. PubMed ID: 30576317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of maladaptive fibrosis and compromised ventricular function in the pressure overloaded heart by a caveolin-1 surrogate peptide.
    Pleasant-Jenkins D; Reese C; Chinnakkannu P; Kasiganesan H; Tourkina E; Hoffman S; Kuppuswamy D
    Lab Invest; 2017 Apr; 97(4):370-382. PubMed ID: 28112757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo.
    Tourkina E; Richard M; Gööz P; Bonner M; Pannu J; Harley R; Bernatchez PN; Sessa WC; Silver RM; Hoffman S
    Am J Physiol Lung Cell Mol Physiol; 2008 May; 294(5):L843-61. PubMed ID: 18203815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple subregions within the caveolin-1 scaffolding domain inhibit fibrosis, microvascular leakage, and monocyte migration.
    Reese CF; Chinnakkannu P; Tourkina E; Hoffman S; Kuppuswamy D
    PLoS One; 2022; 17(2):e0264413. PubMed ID: 35213624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redistribution of glycolipid raft domain components induces insulin-mimetic signaling in rat adipocytes.
    Müller G; Jung C; Wied S; Welte S; Jordan H; Frick W
    Mol Cell Biol; 2001 Jul; 21(14):4553-67. PubMed ID: 11416134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolin-1 regulates store-operated Ca2+ influx by binding of its scaffolding domain to transient receptor potential channel-1 in endothelial cells.
    Kwiatek AM; Minshall RD; Cool DR; Skidgel RA; Malik AB; Tiruppathi C
    Mol Pharmacol; 2006 Oct; 70(4):1174-83. PubMed ID: 16822931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caveolin-1 scaffolding domain peptides enhance anti-inflammatory effect of heme oxygenase-1 through interrupting its interact with caveolin-1.
    Weng P; Zhang XT; Sheng Q; Tian WF; Chen JL; Yuan JJ; Zhang JR; Pang QF
    Oncotarget; 2017 Jun; 8(25):40104-40114. PubMed ID: 28402952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities.
    Couet J; Sargiacomo M; Lisanti MP
    J Biol Chem; 1997 Nov; 272(48):30429-38. PubMed ID: 9374534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of caveolin scaffolding domain alters cancer cell migration.
    Okada S; Raja SA; Okerblom J; Boddu A; Horikawa Y; Ray S; Okada H; Kawamura I; Murofushi Y; Murray F; Patel HH
    Cell Cycle; 2019 Jun; 18(11):1268-1280. PubMed ID: 31116089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin-1 regulates leucocyte behaviour in fibrotic lung disease.
    Tourkina E; Richard M; Oates J; Hofbauer A; Bonner M; Gööz P; Visconti R; Zhang J; Znoyko S; Hatfield CM; Silver RM; Hoffman S
    Ann Rheum Dis; 2010 Jun; 69(6):1220-6. PubMed ID: 20410070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion 101 residue at caveolin-1 scaffolding domain peptides impairs the ability of increasing heme oxygenase-1 activity.
    Jin LG; Zeng S; Sun XQ; Wu C; Chen JL; Cui M; Pang QF
    Int Immunopharmacol; 2018 Oct; 63():137-144. PubMed ID: 30092496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolin-1 scaffolding domain peptide prevents hyperoxia-induced airway remodeling in a neonatal mouse model.
    Vogel ER; Manlove LJ; Kuipers I; Thompson MA; Fang YH; Freeman MR; Britt RD; Faksh A; Yang B; Prakash YS; Pabelick CM
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L99-L108. PubMed ID: 31042080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phospho-caveolin-1 scaffolding domain dampens force fluctuations in focal adhesions and promotes cancer cell migration.
    Meng F; Saxena S; Liu Y; Joshi B; Wong TH; Shankar J; Foster LJ; Bernatchez P; Nabi IR
    Mol Biol Cell; 2017 Aug; 28(16):2190-2201. PubMed ID: 28592633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cavtratin, a caveolin-1 scaffolding domain peptide, on oligodendroglial signaling cascades.
    Schmitz M; Zerr I; Althaus HH
    Cell Mol Neurobiol; 2011 Oct; 31(7):991-7. PubMed ID: 21523467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the interaction between the protein kinase A catalytic subunit and caveolin-1 scaffolding domain with shotgun scanning, oligomer complementation, NMR, and docking.
    Levin AM; Coroneus JG; Cocco MJ; Weiss GA
    Protein Sci; 2006 Mar; 15(3):478-86. PubMed ID: 16452625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer.
    Engelman JA; Lee RJ; Karnezis A; Bearss DJ; Webster M; Siegel P; Muller WJ; Windle JJ; Pestell RG; Lisanti MP
    J Biol Chem; 1998 Aug; 273(32):20448-55. PubMed ID: 9685399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic cell-permeable caveolin-1 scaffolding domain peptide activates phagocytosis of Escherichia coli by regulating Rab5 activity.
    Hagiwara M; Matsushita K
    Z Naturforsch C J Biosci; 2020 Sep; 75(9-10):333-337. PubMed ID: 32452824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palmitoylation of caveolin-1 at a single site (Cys-156) controls its coupling to the c-Src tyrosine kinase: targeting of dually acylated molecules (GPI-linked, transmembrane, or cytoplasmic) to caveolae effectively uncouples c-Src and caveolin-1 (TYR-14).
    Lee H; Woodman SE; Engelman JA; Volonté D; Galbiati F; Kaufman HL; Lublin DM; Lisanti MP
    J Biol Chem; 2001 Sep; 276(37):35150-8. PubMed ID: 11451957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14: recruitment of C-terminal Src kinase.
    Cao H; Courchesne WE; Mastick CC
    J Biol Chem; 2002 Mar; 277(11):8771-4. PubMed ID: 11805080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.